Clinical trial

Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment

NCT00149175

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Blood sampling, skin biopsy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2002-12-01

PhaseN/A

Conditions

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Dementiaverified · MONDO: dementia

Neurodegenerative Disordersunresolved

Interventions

Blood sampling, skin biopsyOTHER

Sponsors & collaborators

Institut National de la Santé Et de la Recherche Médicale, Francelead sponsor

Aventis Pharmaceuticalscollaborator

Mapped research locations

ParisFrance3 MarseilleFrance1 StrasbourgFrance1 NantesFrance1 RennesFrance1 NiceFrance1 CaenFrance1 RouenFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00149175 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.